Siltuximab for Patients With Idiopathic Multicentric Castleman Disease
Researchers evaluated an approach to treatment guided by histopathologic subtype in patients with idiopathic multicentric Castleman disease.
General Hematology
How Doctors Can Cope With Psychological Distress During the Pandemic
When talking about work issues, Dr Bernstein recommends trying not to focus too much on how awful things are because it can be disheartening.
FDA Requires Boxed Warning Update for Benzodiazepines
Benzodiazepines are widely used to treat a variety of conditions including anxiety disorders, insomnia and seizures.
Red Blood Cell Distribution Width, Mortality Tied in COVID-19
Elevated RDW and increase in RDW during hospitalization linked to increased mortality risk.
BCMA-Directed CAR T-Cell Therapy Gets Priority Review for Multiple Myeloma
The BLA is supported by data from the open-label, single-arm phase 2 KarMMa study.
Diagnosis, Risk-Stratification, Management Updates in Myelodysplastic Syndromes
An overview of the diagnosis and management of MDS, including recent treatment, was discussed in a paper published in the American Journal of Hematology.
Acute Medical Oncology Admissions During the COVID-19 Pandemic
Patients in Ireland logged shorter hospital stays and had fewer emergency department visits during the COVID-19 pandemic.
Germline Factors Affect Molecular Response to Treatment for Polycythemia Vera
Germline polymorphisms can affect response to treatment in people with polycythemia vera.
Tenapanor Under Review for Hyperphosphatemia in CKD
Tenapanor is a first-in-class oral medication that works by blocking the NHE3 transporter in the gastrointestinal tract.
FDA to Review Avacopan for ANCA-Associated Vasculitis
Avacopan is an orally-administered, small molecule designed to selectively block the complement 5a receptor on destructive inflammatory cells such as blood neutrophils.
-
Loading...
-
Loading...
Next post in General Hematology
